Catalent
CTLT
#1496
Rank
C$16.55 B
Marketcap
$91.21
Share price
0.00%
Change (1 day)
56.40%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$1.73

According to Catalent's latest financial reports the company's current EPS (TTM) is -$1.85. In 2022 the company made an earnings per share (EPS) of $3.26 a decrease over its 2021 EPS that were of $4.70.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.73-153.02%
2022$3.26-30.58%
2021$4.7079.67%
2020$2.61114.12%
2019$1.22-15%
2018$1.4475.44%
2017$0.82-22.97%
2016$1.06-59.56%
2015$2.63282.05%
2014$0.69-378.2%
2013-$0.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.14-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.08-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.03 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$9.18-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA